Adherex Technologies


Adherex
Latest News
bullet ADHEREX REPORTS FIRST QUARTER 2009 FINANCIAL RESULTS
bullet Adherex Reports 2008 Fiscal Results


Rodman & Renshaw 10th Annual Healthcare Conference Webcast
Nov. 12, 2008; 2:00 p.m. ET
Listen to our Webcast
ASCO Video: Cadherins and Cadherin Switching File 2.1 MB
2009 ASCO Poster: ADH-1 PDF 200 KB
WRAL.com: Video on ADH-1 and ILI Melphalan in Melanoma See the Video
Adherex Technologies Inc.
  • A team of experts dedicated to identifying, developing and commercializing novel cancer therapeutics
  • A diversified portfolio of innovative cancer compounds in preclinical and clinical development
  • Three products in advanced development, each representing a major therapeutic and commercial opportunity

Adherex is focused on developing solutions to unmet needs in cancer